BrainStorm Cell Therapeutics (BCLI)

Number of shares outstanding as of July 2026 : 11,034,775

According to BrainStorm Cell Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 11,034,775. At the end of 2026 the company had 11,034,775 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for BrainStorm Cell Therapeutics from 2025 to 2026

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2026	11.03 M	0.24%
2025	11 M	107.32%
2024	5.3 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Biogen BIIB	147,200,000	1,233.96%	🇺🇸 USA
Gilead Sciences GILD	1,242,000,000	11,155.33%	🇺🇸 USA
Seagen SGEN	188,135,000	1,604.93%	🇺🇸 USA
Cytokinetics CYTK	123,273,000	1,017.13%	🇺🇸 USA
Agenus AGEN	37,941,000	243.83%	🇺🇸 USA
Acceleron Pharma XLRN	53,824,600	387.77%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for BrainStorm Cell Therapeutics (BCLI)

Number of shares outstanding as of July 2026 : 11,034,775